Title : High pathologic complete response in Her2-positive, early-stage breast cancer to a novel nonanthracycline neoadjuvant chemotherapy.

Pub. Date : 2015 Feb

PMID : 25065563

1 Functional Relationships(s)
Compound Name
Protein Name
1 We hypothesized that the combination of neoadjuvant nab-paclitaxel followed by vinorelbine could represent a nonanthracycline-based treatment option for early-stage Her2-overexpressing breast cancer. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens